Isoflavones and cognitive function in older women: the SOy and Postmenopausal Health In Aging (SOPHIA) Study
- 1 May 2003
- journal article
- clinical trial
- Published by Ovid Technologies (Wolters Kluwer Health) in Menopause
- Vol. 10 (3), 196-202
- https://doi.org/10.1097/00042192-200310030-00004
Abstract
This study examines the effects of a dietary supplement of isoflavones on cognitive function in postmenopausal women. Participants for this 6-month, double-blind, randomized, placebo-controlled clinical trial were women who were in good health, were postmenopausal at least 2 years, and were not using estrogen replacement therapy. Between July 24, 2000, and October 31, 2000, 56 women aged 55 to 74 years were randomized; 2 in the placebo group and 1 in the active treatment group did not complete the 6-month evaluation, and none withdrew because of adverse effects. Women randomized to active treatment (n = 27) took two pills per day, each containing 55 mg of soy-extracted isoflavones (110 mg total isoflavones per day; Healthy Woman: Soy Menopause Supplement, Personal Products Company, McNeil-PPC Inc., Skillman, NJ, USA). Women assigned to placebo (n = 26) took two identical-appearing pills per day containing inert ingredients. Cognitive function tests administered at baseline and follow-up included the following: Trails A and B, category fluency, and logical memory and recall (a paragraph recall test assessing immediate and delayed verbal memory). At baseline, all women were cognitively intact; there were no significant differences by treatment assignment in age, education, depressed mood, or cognitive function (all P values > 0.10). Compliance was 98% and 97%, respectively, in the placebo and treatment groups; all women took at least 85% of their pills. The women in the treatment group did consistently better, both as compared with their own baseline scores and as compared with the placebo group responses at 6 months. Comparisons of percentage change in cognitive function between baseline and follow-up showed greater improvement in category fluency for women on active treatment as compared with the case of those on placebo (P = 0.02) and showed (nonsignificantly) greater improvement on the two other tests of verbal memory and Trails B. These results suggest that isoflavone supplementation has a favorable effect on cognitive function, particularly verbal memory, in postmenopausal women.Keywords
This publication has 25 references indexed in Scilit:
- Eating soya improves human memoryPsychopharmacology, 2001
- Cognitive Function in Postmenopausal Women Treated with RaloxifeneNew England Journal of Medicine, 2001
- Hormone Replacement Therapy and CognitionJAMA, 2001
- Brain Aging and Midlife Tofu ConsumptionJournal of the American College of Nutrition, 2000
- Tofu and soy drinks contain phytoestrogensJournal of the American Dietetic Association, 1994
- The Mini‐Mental State Examination: A Comprehensive ReviewJournal of the American Geriatrics Society, 1992
- A psychometric investigation of the standard and short form Beck Depression Inventory.Journal of Consulting and Clinical Psychology, 1981
- “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinicianJournal of Psychiatric Research, 1975
- An Inventory for Measuring DepressionArchives of General Psychiatry, 1961
- Validity of the Trail Making Test as an Indicator of Organic Brain DamagePublished by SAGE Publications ,1958